Evoke Pharma IPO Research Information

Evoke Pharma IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Evoke Pharma, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Evoke Pharma	EVOK - NASDAQ	$12.00-$14.00	$12.00	$11.15	2.1 million	9/25/2013
Underwriter(s): Aegis Capital Corp
Co-Manager(s): Cantor Fitzgerald, Feltl & Co.
Industry: Health Care
Filing(s): Filed 2013-05-24

Evoke Pharma Quote & Chart - Click for current quote - EVOK

About Evoke Pharma (adapted from Evoke Pharma prospectus):
they are a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal, or GI, disorders and diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "EVOK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.